Public-domain · open source
OpenJurist
← 368 F. Supp. 2d 533 - Microstrategy, Inc. v. Netsolve, Inc.

368 F. Supp. 2d 533 - Microstrategy, Inc. v. Netsolve, Inc.’s Empirical Analysis

2005

Citation profile

11
cited by 11 later decisions
2
states following
August 2021
most recently cited

3 state decisions

How this case has been cited

Cited by 11 later decisions — most recently August 2021

3 state decisions

60200520102020decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Applies 17 U.S.C. § 102 (§ 101 of the Copyright Act of 1976) · 17 U.S.C. § 106 (§ 101 of the Copyright Act of 1976) · 17 U.S.C. § 301 (§ 101 of the Copyright Act of 1976)

Relies on Conley v. Gibson · Harper & Row, Publishers, Inc. v. Nation Enterprises · Mylan Laboratories, Inc. v. Matkari · Harper & Row, Publishers, Inc. v. Nation Enterprises · United States ex rel. Berge v. Board of Trustees of the University of Alabama

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 11 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “the defendant's acceptance or retention of the benefit [was] under circumstances that 'render it inequitable for the defendant to retain the benefit without paying for its value.'”
    1 later decision quote this exact passage · from the majority
  2. “an unjust enrichment claim may survive a preemption challenge if plaintiff[ ] demonstrate[s] that defendants were unjustly enriched by 'material beyond copyright protection.'”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.